(Q37826019)

23 August 2017

1 reference

title

Intravenous N-acetylcysteine in the prevention of contrast media-induced nephropathy (English)

1 reference

23 August 2017

1 reference

Spencer M Anderson

1

1 reference

23 August 2017

Zoon H Park

series ordinal

2

1 reference

23 August 2017

Ramesh V Patel

series ordinal

3

1 reference

23 August 2017

language of work or name

English

0 references

publication date

4 January 2011

1 reference

Annals of Pharmacotherapy

23 August 2017

published in

1 reference

23 August 2017

volume

45

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

101-107

1 reference

Contrast-induced kidney injury: focus on modifiable risk factors and prophylactic strategies.

23 August 2017

cites work

1 reference

Clinical practice. Preventing nephropathy induced by contrast medium

21 January 2018

1 reference

Reactive oxygen species and the pathogenesis of radiocontrast-induced nephropathy

21 January 2018

1 reference

Facts and fallacies concerning the prevention of contrast medium-induced nephropathy

21 January 2018

1 reference

The Prevention of Radiocontrast-Agent–Induced Nephropathy by Hemofiltration

21 January 2018

1 reference

N-acetylcysteine for prevention of radiocontrast induced nephrotoxicity: the importance of dose and route of administration

21 January 2018

1 reference

Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine

21 January 2018

1 reference

Systematic review of the impact of N-acetylcysteine on contrast nephropathy

21 January 2018

1 reference

N-acetylcysteine for prevention of radiographic contrast material-induced nephropathy: is the intravenous route best?

21 January 2018

1 reference

N-acetylcysteine in the prevention of radiocontrast-induced nephropathy

21 January 2018

1 reference

Comparison of oral and i.v. acetylcysteine in the treatment of acetaminophen poisoning

21 January 2018

1 reference

Adverse reactions associated with acetylcysteine

21 January 2018

1 reference

The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable

21 January 2018

1 reference

Cystatin C and contrast-induced acute kidney injury.

21 January 2018

1 reference

Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy

21 January 2018

1 reference

Reducing the risk of contrast-induced nephropathy: a perspective on the controversies

21 January 2018

1 reference

N-acetylcysteine and contrast-induced nephropathy in primary angioplasty.

21 January 2018

1 reference

A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity

21 January 2018

1 reference

A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study

21 January 2018

1 reference

Acetylcysteine, coronary procedure and prevention of contrast-induced worsening of renal function: which benefit for which patient?

21 January 2018

1 reference

I.v. N-acetylcysteine and emergency CT: use of serum creatinine and cystatin C as markers of radiocontrast nephrotoxicity.

21 January 2018

1 reference

Prevention of contrast-induced nephropathy in vascular patients undergoing angiography: a randomized controlled trial of intravenous N-acetylcysteine.

21 January 2018

1 reference

A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effect

21 January 2018

1 reference

Perioperative N-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing cabg surgery: a randomized controlled trial.

21 January 2018

1 reference

N-acetylcysteine for the prevention of kidney injury in abdominal aortic surgery: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

N-acetylcysteine in cardiovascular-surgery-associated renal failure: a meta-analysis

21 January 2018

1 reference

Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1P275

1 reference

23 August 2017

1 reference